Successful anti-cancer immune responses reported in phase 1 trial of a personalized cancer vaccine for #kidneycancer. Research in Nature led by @drchoueiri.bsky.social #PatrickOtt #CatherineWu #DerinKeskin (all of @danafarber.bsky.social) and David Braun of @yalecancer.bsky.social. https://bit.ly/3CDIT3n